Aryl hydrocarbon receptor agonists directly activate estrogen receptor α in MCF-7 breast cancer cells

Biological Chemistry

Volumn 387, Issue 9, 2006, Pages 1209-1213

  Liu, Shengxi ^a   Abdelrahim, Maen ^a   Khan, Shaheen ^b   Ariazi, Eric ^c   Jordan, V Craig ^c   Safe, Stephen ^a,b,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

AhR; Estrogenicity; Selective AhR modulators; Transactivation

Indexed keywords

1,3,8 TRICHLORO 6 METHYLDIBENZOFURAN; 3,3' DIINDOLYLMETHANE; 3,3',4,4' TETRACHLOROBIPHENYL; ANTINEOPLASTIC AGENT; ARYL HYDROCARBON RECEPTOR STIMULATING AGENT; BENZO[A]PYRENE; CHRYSIN; CYTOCHROME P450 1A1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HORMONE RECEPTOR STIMULATING AGENT; PROTEIN PS2; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; STRUCTURAL HOMOLOGY; TRANSACTIVATION;

BENZO(A)PYRENE; BENZOFURANS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; ESTROGEN RECEPTOR ALPHA; FLAVONOIDS; HUMANS; INDOLES; LIGANDS; METHYLCHOLANTHRENE; POLYCHLORINATED BIPHENYLS; PRESENILIN-2; PROMOTER REGIONS (GENETICS); RECEPTORS, ARYL HYDROCARBON; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACHLORODIBENZODIOXIN;

EID: 33748806035     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.149     Document Type: Article

References (24)

1. Abdelrahim, M., Smith R. III, and Safe, S. (2003). Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol. Pharmacol. 63, 1373-1381.
2. Abdelrahim, M., Ariazi, E., Kim, K., Khan, S., Barhoumi, R., Burghardt, R., Liu, S., Hill, D., Finnell, R., Wlodarczyk, B., et al. (2006). 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α. Cancer Res. 66, 2459-2467.
3. Beischlag, T.V. and Perdew, G.H. (2005). ERa-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J. Biol. Chem. 280, 21607-21611.
4. Bjeldanes, L.F., Kim, J.Y., Grase, K.R., Bartholomew, J.C., and Bradfield, C.A. (1991). Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo-comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 88, 9543-9547.
5. Bradfield, C.A. and Poland, A. (1988). A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor. Mol. Pharmacol. 34, 682-688.
6. Denison, M.S. and Nagy, S.R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
7. Gould, J.C., Leonard, L.S., Maness, S.C., Wagner, B.L., Connor, K., Zacharewski, T., Safe, S., McDonnell, D.P., and Gaido, K.W. (1998). Bisphenol A interacts with the estrogen receptor a in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142, 203-214.
8. Hoivik, D., Willett, K., Wilson, C., and Safe, S. (1997). Estrogen does not inhibit 2, 3, 7, 8-tetraclorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J. Biol. Chem. 272, 30270-30274.
9. Kharat, I. and Saatcioglu, F. (1996). Antiestrogenic effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. J. Biol. Chem. 271, 10533-10537.
10. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S., Van der Saag, P.T., Van der Burg, B., and Gustafsson, J.-Å. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263.
11. Lee, H.J., Chattopadhyay, S., Gong, E.Y., Ahn, R.S., and Lee, K. (2003). Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol. Sci. 75, 40-46.
12. Liu, H., Wormke, M., Safe, S., and Bjeldanes, L.F. (1994). Indolo[3,2-b]carbazole: a dietary factor which exhibits both antiestrogenic and estrogenic activity. J. Natl. Cancer Inst. 86, 1758-1765.
13. Matthews, J., Wihlen, B., Thomsen, J., and Gustafsson, J.A. (2005). Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor α to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell. Biol. 25, 5317-5328.
14. Ohtake, F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., Tohyama C., Krust A., Mimura J., Chambon P., et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550.
15. Pearce, S.T., Liu, H., Radhakrishnan, I., Abdelrahim, M., Safe, S., and Jordan, V.C. (2004). Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) with estrogen receptor α. Cancer Res. 64, 2889-2897.
16. Piskorska-Pliszczynska, J., Keys, B., Safe, S., and Newman, M.S. (1986). The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol. Lett. 34, 67-74.
17. Poland, A. and Knutson, J.C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
18. Poland, A., Glover, E., and Kende, A.S. (1976). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251, 4936-4946.
19. Safe, S. and Wormke, M. (2003). Inhibitory aryl hydrocarbon-estrogen receptor a crosstalk and mechanisms of action. Chem. Res. Toxicol. 16, 807-816.
20. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). CRC Crit. Rev. Toxicol. 21, 51-88.
21. Safe, S. (1995). Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Therap. 67, 247-281.
22. Wilson, C.L. and Safe, S. (1998). Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 26, 657-671.
23. Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., and Safe, S. (2003). The aryl hydrocarbon receptor mediates degradation of the estrogen receptor a through activation of proteasomes. Mol. Cell. Biol. 23, 1843-1855.
24. Zhang, S., Qin, C., and Safe, S.H. (2003). Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Persp. 111, 1877-1882.